Back to Search
Start Over
Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells.
- Source :
-
The journal of gene medicine [J Gene Med] 2011 Apr; Vol. 13 (4), pp. 200-8. - Publication Year :
- 2011
-
Abstract
- Background: Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Neutrophil-dominated inflammation and chronic bacterial infection are still considered the primary cause of bronchioectasis, respiratory failure and consequent death in CF patients. Activation of nuclear factor (NF)-κB is responsible for overproduction of cytokines, such as interleukin (IL)-6 and IL-8, in airways of CF patients. Thus, decoy oligodeoxynucleotides against NF-κB (dec-ODN) may limit lung inflammation in CF. In the present study, we studied the effects of dec-ODN delivered through biodegradable and respirable poly(D,L-lactide-co-glycolide) large porous particles (LPP) on IL-6 and IL-8 mRNA expression as well as NF-κB/DNA binding activity in cystic fibrosis cells stimulated with lipopolysaccharide (LPS) from Pseudomonas aeruginosa.<br />Methods: dec-ODN LPP were prepared by a modified double emulsion technique and characterized in terms of size, morphology, tapped density and dec-ODN loading. Human epithelial bronchial IB3-1 (CFTR-mutated) as well as S9 (CFTR-corrected) were stimulated with LPS from P. aeruginosa for 24 and 72 h in the absence or presence of naked dec-ODN or dec-ODN LPP.<br />Results: Stimulation of cells with LPS from P. aeruginosa caused an increase of IL-6 and IL-8 mRNA levels, which were significantly inhibited by dec-ODN LPP at 24 and 72 h, whereas naked dec-ODN inhibited those only at 24 h. Similar effects were exhibited by dec-ODN LPP or naked dec-ODN on NF-κB/DNA binding activity.<br />Conclusions: Our observations indicate that respirable biodegradable dec-ODN LPP may represent a promising strategy for inhibiting NF-κB transcriptional activity and related gene expression and, thus, reduce lung chronic inflammation in CF patients.<br /> (Copyright © 2011 John Wiley & Sons, Ltd.)
- Subjects :
- Analysis of Variance
Bronchi immunology
Cells, Cultured
DNA Primers genetics
Electrophoretic Mobility Shift Assay
Gene Expression Regulation immunology
Humans
Interleukin-6 immunology
Interleukin-8 immunology
Lipopolysaccharides
NF-kappa B metabolism
Oligodeoxyribonucleotides administration & dosage
Pseudomonas aeruginosa chemistry
Reverse Transcriptase Polymerase Chain Reaction
Transcription Factors administration & dosage
Bronchi cytology
Cystic Fibrosis immunology
Gene Expression Regulation drug effects
Interleukin-6 metabolism
Interleukin-8 metabolism
Oligodeoxyribonucleotides pharmacology
Transcription Factors pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1521-2254
- Volume :
- 13
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The journal of gene medicine
- Publication Type :
- Academic Journal
- Accession number :
- 21322102
- Full Text :
- https://doi.org/10.1002/jgm.1546